Abstract
Amyloidosis consists of a group of diseases that have in common the extracellular deposition of a substance composed primarily of amyloid type proteins. Amyloid proteins have ultrastructural and biochemical specific properties that, through specific staining methods, demonstrate their fibrillar character and structure and distribution in the tissue in which they are deposited. The physical presence of deposits of an amyloid substance can cause dysfunction in tissues and organs by the interaction of fibrils with local receptors and deposit cytotoxicity. The clinical presentation varies according to the affected tissue and organ; it can be subtle and nonspecific, such as fatigue and weight loss, and serious with renal, cardiac, and gastrointestinal insufficiency and peripheral autonomic and/or sensitive-motor neuropathy. In general, though several organs may be affected, one form might dominate. Amyloidosis can be primary, hereditary, or associated with various clinical situations; being primary if it is not associated with any other disease. The secondary form of the disease occurs primarily associated with neoplasms and inflammatory or chronic infectious diseases.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.